Position in FATE
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$70,880
New position
Shares Held
26,252
first reported quarter
Ownership
0.022%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#84
of 155 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Proficio Capital Partners LLC holds $4,501,972 across 8 Biotechnology names. FATE ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYMR |
Kymera Therapeutics, Inc.
|
11,045 | $1,266,530 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,184 | $1,084,858 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
909 | $566,797 | |
| 4 | INCY |
Incyte Corp
|
4,483 | $508,192 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
1,786 | $430,372 | |
| 6 | MRNA |
Moderna, Inc.
|
4,251 | $297,697 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
919 | $276,646 | |
| 8 | FATE |
Fate Therapeutics Inc
This page
|
26,252 | $70,880 |
All Filings in FATE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $70,880 | 26,252 | Shares | Sole | 2026-08-17 | |
| No filing history on record for this holder in this stock. | ||||||